27 results
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
WILL CAUSE IRREPARABLE INJURY AND MONEY DAMAGES WILL NOT PROVIDE AN ADEQUATE REMEDY THEREFOR, AND IN THE EVENT OF SUCH A BREACH ALL PARTIES CONSENT
8-K
EX-10.3
n8ygiaq
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
5j0gtc649g mk168
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
10-K
jephh6 k6
25 Mar 21
Annual report
12:00am
424B4
o3cy0jjsgaauy 6vik0
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
6wgh0 5f12en4x318y
6 Jan 21
Draft registration statement
12:00am
10-Q
x1o42i1grr80vdx 5azw
12 Nov 20
Quarterly report
4:16pm